my account log out | |
Anti-GRM2 VHH |
Create: 01/11/2017 |
Expired Date: | 01/02/2018 |
Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
Message: | The anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibody target mGluR2 which contribute to the fine-tuning of synaptic efficacy. The llama-derived anti-mGluR2 single domain antibody act as a positive allosteric modulator and are able to stabilized the active state of mGluR2. Therefore, the anti-mGluR2 single domain antibody can be useful in the treatment of schizophrenia, epilepsy, addiction/drug dependence, Parkinson's disease, pain, sleep disorders and Huntington's disease. |
City: | Shirley[US] |
Location: | |
Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 214 | |
Feb 01 2023 | GVBE Buffer | 214 | |
Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 208 | |
Aug 30 2019 | Anti-HSV-2 gH Antibody | 392 | |
Aug 30 2019 | Anti-L. major LPG Antibody | 476 | |
Aug 30 2019 | Anti-DENV-1 Antibody | 385 | |
Aug 30 2019 | Anti-BPV-1 L1 Antibody | 401 | |
Aug 30 2019 | Anti-H3N2 HA Antibody | 387 | |
Aug 30 2019 | Anti-EIAV env Antibody | 411 |
Copyright © toextrade Inc. All rights reserved. Contact us |